Scope Health acquires Eyetamins supplements
Scope Health announced its acquisition of Eyetamins, an eye health supplement brand created by neuro-ophthalmologist Kaushal Kulkarni, MD, according to a press release.
“This new partnership underscores our shared commitment to eye health innovation and improved patient outcomes,” Kulkarni said in the release. “I am excited to be a part of the continuing and future story of Eyetamins as it grows out under the Scope and Optase umbrella.”
Eyetamins supplements deliver targeted nutrition to benefit long-term eye health and vision using clinically backed ingredients.
According to the release, the acquisition will allow customers to access a wider range of products and services with enhanced customer experience. Eyetamins products will still be available through its website and Amazon.
Read more about